Showing results (111-120 of 189) with videos related to
Sort By:
Pageof 19
The Journal of Rheumatology|August 1, 2024
The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis SymptomsLisa Christopher-Stine, Anna Ciesluk, Hector Chinoy, et al.Journal of the American Society of Nephrology : JASN|April 17, 2009
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritisGerald B Appel, Gabriel Contreras, Mary Anne Dooley, et al.Revista Brasileira De Medicina Do Trabalho : Publicacao Oficial Da Associacao Nacional De Medicina Do Trabalho-Anamt|August 27, 2025
Exhaustion and performativity: the relationship between psychosocial factors and burnout syndrome in companiesEuda Kaliani Gomes Teixeira Rocha, Hélio Soares de França, Carolina Pontual Cardoso de Vasconcelos, et al.Seminars in Arthritis and Rheumatism|June 6, 2022
Adalimumab or etanercept as first line biologic therapy in enthesitis related arthritis (ERA) - a drug-survival single centre study spanning 10 yearsMuhammad Ra Shipa, Nicola Heyer, Rashid Mansoor, et al.Codas|July 19, 2023
Satisfaction and quality of life in cochlear implant users with long sensory deprivationAlleluia Lima Losno Ledesma, Kétlim Dos Santos Evangelista, Driely Maria Leandro de Alexandria, et al.Plos One|June 3, 2016
Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid SyndromeCharis Pericleous, Isabel Ferreira, Orietta Borghi, et al.Journal of Thrombosis and Haemostasis : JTH|September 4, 2020
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and HaemostasisStéphane Zuily, Hannah Cohen, David Isenberg, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Thrombin binding predicts the effects of sequence changes in a human monoclonal antiphospholipid antibody on its in vivo biologic actionsIan Giles, Charis Pericleous, Xiaowei Liu, et al.Rheumatology (Oxford, England)|October 19, 2017
Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder indexKenneth C Kalunian, Murray B Urowitz, David Isenberg, et al.Arthritis and Rheumatism|August 1, 2007
Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosusKathleen McElhone, Janice Abbott, Joanna Shelmerdine, et al.Pageof 19